Sandy Spring Bank’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $3.86M | Sell |
8,868
-4,312
| -33% | -$1.73M | 0.16% | 124 |
|
|
2024
Q4 | $4.86M | Sell |
13,180
-2,840
| -18% | -$1.19M | 0.2% | 108 |
|
|
2024
Q3 | $8.33M | Sell |
16,020
-747
| -4% | -$399K | 0.34% | 65 |
|
|
2024
Q2 | $9.09M | Sell |
16,767
-1,757
| -9% | -$929K | 0.4% | 60 |
|
|
2024
Q1 | $9.61M | Sell |
18,524
-300
| -2% | -$149K | 0.44% | 57 |
|
|
2023
Q4 | $8.88M | Sell |
18,824
-428
| -2% | -$198K | 0.44% | 56 |
|
|
2023
Q3 | $8.38M | Buy |
19,252
+285
| +2% | +$129K | 0.47% | 48 |
|
|
2023
Q2 | $8.43M | Sell |
18,967
-29
| -0.2% | -$13.4K | 0.45% | 53 |
|
|
2023
Q1 | $8.73M | Buy |
18,996
+107
| +0.6% | +$50.9K | 0.5% | 48 |
|
|
2022
Q4 | $9.69M | Buy |
18,889
+405
| +2% | +$206K | 0.58% | 40 |
|
|
2022
Q3 | $8.4M | Buy |
18,484
+83
| +0.5% | +$39.7K | 0.53% | 45 |
|
|
2022
Q2 | $8.88M | Sell |
18,401
-846
| -4% | -$419K | 0.53% | 45 |
|
|
2022
Q1 | $9.46M | Buy |
19,247
+412
| +2% | +$188K | 0.48% | 51 |
|
|
2021
Q4 | $8.73M | Buy |
18,835
+387
| +2% | +$163K | 0.42% | 59 |
|
|
2021
Q3 | $6.88M | Buy |
18,448
+692
| +4% | +$263K | 0.36% | 66 |
|
|
2021
Q2 | $6.78M | Buy |
17,756
+496
| +3% | +$190K | 0.36% | 67 |
|
|
2021
Q1 | $6.2M | Sell |
17,260
-22
| -0.1% | -$7.08K | 0.36% | 69 |
|
|
2020
Q4 | $5.55M | Buy |
17,282
+541
| +3% | +$166K | 0.34% | 74 |
|
|
2020
Q3 | $4.5M | Buy |
16,741
+687
| +4% | +$185K | 0.31% | 80 |
|
|
2020
Q2 | $4.22M | Sell |
16,054
-170
| -1% | -$45.4K | 0.31% | 82 |
|
|
2020
Q1 | $3.68M | Sell |
16,224
-67
| -0.4% | -$18.3K | 0.33% | 76 |
|
|
2019
Q4 | $4.92M | Buy |
16,291
+219
| +1% | +$60.3K | 0.36% | 72 |
|
|
2019
Q3 | $3.86M | Buy |
16,072
+472
| +3% | +$129K | 0.3% | 84 |
|
|
2019
Q2 | $4.4M | Buy |
15,600
+1,621
| +12% | +$443K | 0.35% | 77 |
|
|
2019
Q1 | $4.01M | Buy |
13,979
+781
| +6% | +$226K | 0.34% | 81 |
|
|
2018
Q4 | $3.47M | Sell |
13,198
-340
| -3% | -$93.5K | 0.33% | 79 |
|
|
2018
Q3 | $3.71M | Buy |
13,538
+59
| +0.4% | +$15.3K | 0.3% | 87 |
|
|
2018
Q2 | $3.21M | Sell |
13,479
-85
| -0.6% | -$19.7K | 0.28% | 94 |
|
|
2018
Q1 | $2.98M | Sell |
13,564
-85
| -0.6% | -$20K | 0.26% | 99 |
|
|
2017
Q4 | $3.07M | Sell |
13,649
-206
| -1% | -$43.9K | 0.28% | 93 |
|
|
2017
Q3 | $2.63M | Sell |
13,855
-135
| -1% | -$25.7K | 0.25% | 107 |
|
|
2017
Q2 | $2.63M | Sell |
13,990
-1,262
| -8% | -$227K | 0.26% | 103 |
|
|
2017
Q1 | $2.52M | Sell |
15,252
-782
| -5% | -$124K | 0.25% | 106 |
|
|
2016
Q4 | $2.31M | Sell |
16,034
-100
| -0.6% | -$13.4K | 0.24% | 110 |
|
|
2016
Q3 | $2.02M | Sell |
16,134
-237
| -1% | -$30.6K | 0.22% | 128 |
|
|
2016
Q2 | $2.15M | Sell |
16,371
-599
| -4% | -$82K | 0.25% | 113 |
|
|
2016
Q1 | $2.36M | Sell |
16,970
-132
| -0.8% | -$17.6K | 0.27% | 96 |
|
|
2015
Q4 | $2.38M | Buy |
17,102
+400
| +2% | +$55.1K | 0.28% | 97 |
|
|
2015
Q3 | $2.34M | Sell |
16,702
-84
| -0.5% | -$12.6K | 0.29% | 92 |
|
|
2015
Q2 | $2.76M | Sell |
16,786
-184
| -1% | -$29.4K | 0.31% | 89 |
|
|
2015
Q1 | $2.62M | Sell |
16,970
-2,480
| -13% | -$353K | 0.3% | 92 |
|
|
2014
Q4 | $2.44M | Sell |
19,450
-425
| -2% | -$52.5K | 0.29% | 98 |
|
|
2014
Q3 | $2.38M | Sell |
19,875
-250
| -1% | -$28.7K | 0.29% | 101 |
|
|
2014
Q2 | $2.17M | Sell |
20,125
-300
| -1% | -$30.9K | 0.27% | 106 |
|
|
2014
Q1 | $2.03M | Buy |
20,425
+1,715
| +9% | +$155K | 0.31% | 99 |
|
|
2013
Q4 | $1.73M | Sell |
18,710
-462
| -2% | -$41.1K | 0.24% | 116 |
|
|
2013
Q3 | $1.6M | Buy |
19,172
+350
| +2% | +$30K | 0.24% | 118 |
|
|
2013
Q2 | $1.54M | Buy |
+18,822
| New | +$1.41M | 0.24% | 116 |
|
Other funds holding ELV
Sandy Spring Bank's ELV Position: Q1 2025 in Review
Sandy Spring Bank reduced its Elevance Health (ELV) stake by 33% in Q1 2025, selling an estimated $1.73M and leaving 8,868 shares worth $3.86M. The position accounts for 0.16% of the portfolio, ranked #124.
Sandy Spring Bank first reported a position in ELV in Q2 2013 and has held it in 48 quarters since. The position peaked at $9.69M in Q4 2022. 1,661 funds tracked by Wall St. Rank hold ELV as of Q1 2025.
- Sandy Spring Bank held 8,868 shares of Elevance Health worth $3.86M as of Q1 2025.
- Sandy Spring Bank sold 4,312 Elevance Health shares in Q1 2025, an estimated $1.73M.
- Elevance Health made up 0.16% of Sandy Spring Bank's portfolio in Q1 2025, its #124 holding.
- Sandy Spring Bank first reported a position in Elevance Health in Q2 2013 and has held it in 48 quarters since.
- Sandy Spring Bank's Elevance Health position peaked at $9.69M in Q4 2022.
- 1,661 funds tracked by Wall St. Rank held Elevance Health as of Q1 2025.
Based on Sandy Spring Bank's 13F filing for Q1 2025, filed 12 May 2025.